Landing page optimization

Demeditec:: Influenza A IgA ELISA

Newsticker:

Infectious Disease
Cat.-No.: DEIFA02

Product: Influenza A IgA ELISA

TEST SPECIFICATIONS

Influenza A IgA ELISA

Technology

ELISA

Kit size

96 Tests

Sample material

Serum or Plasma

Sample preparation

1:101 predilution

Sample volume

5 µl

Standard range

1 – 150 U/ml

Incubation

60 min, 30 min, 20 min at RT

Measuring system

TMB at 450 nm

Sensitivity

1.29 U/ml



Special remarks: The DEMEDITEC Influenza A IgA Antibody ELISA Test Kit has been designed for the the detection and the quantitative determination of specific IgA antibodies against Influenza A in serum and plasma.
The antigen used for coating the plates is a vaccine: Beijing and Sidney 1+2.

The influenza infection is an acute feverish virus infection, which principally leads to an illness of the respiratory tract and appears as an epidemic or pandemic. The infection mostly results from a droplet infection. The virus spreads from the mucous membrane of the upper respiratory to the whole bronchial tract. There the virus and its toxin can lead to a serious inflammation of the bronchial mucosa and a damage of the vessels. After an incubation time of 1 to 3 days the symptoms appear suddenly: Followed by a fast increase of temperature, often accompanied by shivering, the catarrhal leading symptom appears, which contribute to the clinical course beside painful dry cough, tracheitis, laryngitis and frequently a rhinitis and conjunctivitis.The Influenza viruses form a virus group with principally similar morphological, chemical and biological features. The types A, B and C were defined, from which many other variants are known. The distinction of the types will be possible by the different antigenicity of their nucleoproteins, which are coated by a matrix protein with type-specific antigenicity, too. However, both internal antigens are of less importance for the immunity. The essential antigens are the hemagglutinin and the neuraminidase. Both are surface antigens and subject to a permanent change of their antigenicity, which is called drift or shift. The appearence of permanent new Influenza epidemics and pandemics are particularly facilitated by an antigen variability, because the new drift or shift variants infect a population which is only partly immune or in an extreme case completely susceptible to the disease.The determination of the Influenza type (A, B, and C) gives both the clinician and epidemiologist important indications for further actions. Thus Influenza B often leads to a serious clinical course and an epidemic spread of the virus. Similarly, during an Influenza A epidemic, the epidemiological importance and derived measures for the protection of the individual and population primarily stand in the foreground together with the severity of the clinical symptoms.